Form 4 Tracker
Travere Therapeutics, Inc.
TVTX

33 insider filings · Latest: May 19, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
May 15, 2026May 19 4:05 PMTimothy CoughlinDirector
Sale
3,250$43.49$141.3K52,250(D)

View →

May 5, 2026May 6 8:00 PMRoy D. BaynesDirector
Sale
4,500$46.65$209.9K37,500(D)

View →

May 4, 2026May 6 8:00 PMMeckler Jeffrey ADirector
Sale
8,000$45.00$360.0K87,500(D)

View →

May 6, 2026May 6 8:00 PMWilliam E. RoteChief Research Officer
Sale
2,763$43.95$121.4K115,474(D)

View →

May 6, 2026May 6 8:00 PMElizabeth E ReedChief Legal Officer and GC
Sale
2,076$43.95$91.2K105,211(D)

View →

May 5, 2026May 6 8:00 PMElizabeth E ReedChief Legal Officer and GC
Sale
2,174$46.65$101.4K107,287(D)

View →

May 4, 2026May 6 8:00 PMElizabeth E ReedChief Legal Officer and GC
Sale
20,000$45.00$900.0K105,211(D)

View →

May 6, 2026May 6 8:00 PMJula InrigCHIEF MEDICAL OFFICER
Sale
311$43.95$13.7K113,238(D)

View →

May 5, 2026May 6 8:00 PMJula InrigCHIEF MEDICAL OFFICER
Sale
2,174$46.65$101.4K113,549(D)

View →

May 4, 2026May 6 8:00 PMJula InrigCHIEF MEDICAL OFFICER
Sale
20,000$45.00$900.0K111,473(D)

View →

May 5, 2026May 6 8:00 PMPeter HeermaCHIEF COMMERCIAL OFFICER
Sale
2,174$46.65$101.4K140,684(D)

View →

May 6, 2026May 6 8:00 PMEric M DubeDirector, CHIEF EXECUTIVE OFFICER
Sale
22,500$43.95$988.9K432,886(D)

View →

May 6, 2026May 6 8:00 PMChristopher R. ClineCHIEF FINANCIAL OFFICER
Sale
310$43.95$13.6K118,658(D)

View →

May 5, 2026May 6 8:00 PMChristopher R. ClineCHIEF FINANCIAL OFFICER
Sale
2,181$46.65$101.7K118,968(D)

View →

May 1, 2026May 4 4:27 PMRoy D. BaynesDirector
Sale
9,750$44.22$431.1K37,500(D)

View →

Apr 22, 2026Apr 23 4:05 PMWilliam E. RoteChief Research Officer
Sale
9,100$39.09$355.7K113,987(D)

View →

Apr 14, 2026Apr 16 4:05 PMLYONS GARY ADirector
Sale
8,000$41.07$328.6K57,500(D)

View →

Apr 14, 2026Apr 16 4:05 PMRoy D. BaynesDirector
Sale
32,750$41.29$1.4M37,500(D)

View →

Apr 14, 2026Apr 16 4:05 PMSandra CalvinSVP, CHIEF ACCOUNTING OFFICER
Sale
21,977$41.07$902.6K42,353(D)

View →

Apr 14, 2026Apr 15 9:49 PMPeter HeermaCHIEF COMMERCIAL OFFICER
Sale
7,215$41.93$302.5K138,608(D)

View →

Page 1 of 2

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
May 4, 2026May 6 8:00 PMEric M DubeDirector, CHIEF EXECUTIVE OFFICER
Option Exercise
22,50022,500(D)

View →

May 4, 2026May 6 8:00 PMChristopher R. ClineCHIEF FINANCIAL OFFICER
Grant/Award
8,5008,500(D)

View →

May 4, 2026May 6 8:00 PMChristopher R. ClineCHIEF FINANCIAL OFFICER
Option Exercise
4,2504,250(D)

View →

May 1, 2026May 4 4:27 PMRoy D. BaynesDirector
Option Exercise
9,750$6.829,750(D)

View →

Apr 14, 2026Apr 16 4:05 PMLYONS GARY ADirector
Option Exercise
8,000$16.330(D)

View →

Apr 14, 2026Apr 16 4:05 PMRoy D. BaynesDirector
Option Exercise
32,750$21.386,750(D)

View →

Apr 14, 2026Apr 16 4:05 PMSandra CalvinSVP, CHIEF ACCOUNTING OFFICER
Option Exercise
15,250$22.4019,500(D)

View →

Apr 14, 2026Apr 15 9:47 PMElizabeth E ReedChief Legal Officer and GC
Option Exercise
37,500$19.0820,000(D)

View →

Apr 6, 2026Apr 7 6:17 PMRoy D. BaynesDirector
Option Exercise
10,000$26.520(D)

View →

Apr 1, 2026Apr 2 5:55 PMEric M DubeDirector, CHIEF EXECUTIVE OFFICER
Option Exercise
60,000$15.460(D)

View →

Apr 1, 2026Apr 2 5:55 PMElizabeth E ReedChief Legal Officer and GC
Option Exercise
10,000$15.4645,000(D)

View →

Mar 16, 2026Mar 18 4:05 PMElizabeth E ReedChief Legal Officer and GC
Option Exercise
10,000$19.0810,000(D)

View →

← Previous

Page 2 of 2